课题基金 / 基金详情

MOLECULAR-BIOLOGICAL APPROACHES TO HEAD AND NECK CANCER AND THE CLINICAL APPLICATION

MOLECULAR-BIOLOGICAL APPROACHES TO HEAD AND NECK CANCER AND THE CLINICAL APPLICATION
头颈癌的分子生物学方法及其临床应用
批准号:
10470359
负责人:
YAMANAKA Noboru
金额:
$6.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

YAMANAKA Noboru的其他基金

相似基金

相关文献

中文摘要
翻译
1. 间咽癌中p53改变的多因素分析:采用免疫组织染色法检测p53蛋白。26例肿瘤中有15例(62%)存在显著过表达。在临床III期和IV期,p53过表达患者的5年总生存率为0%,而阴性患者的5年总生存率为41.7%。采用elisa法检测了中咽癌患者血清中p53抗体的含量,40%的患者血清中p53抗体呈阳性。血清学分析是有利的,因为它不需要肿瘤样本。此外,还可用于患者的随访。粘附分子、蛋白水解酶和血管生成因子在头颈癌转移中的意义:头颈癌组织中E-cadherin表达及其与生存率的关系研究显示,E-cadherin表达降低与预后不良相关。因此,e -钙粘蛋白的功能可能与肿瘤细胞的转移活性密切相关。血管生成是转移性菌落扩张和肿瘤生长所必需的。来源于头颈部癌细胞的细胞系显示出大量血管内皮生长因子(VEGF)的产生,这是一种最常见的血管生成因子,表明肿瘤细胞为自身生长诱导血管生成。结合免疫组织化学技术和计算机图像分析清楚地表明微血管密度是头颈部肿瘤远处转移的重要预后因素。通过抗E-cadherin抗体抑制E-cadherin功能可上调VEGF的产生,这有力地支持了E-cadherin功能与血管生成的密切关系。ELISA法检测头颈癌患者血清中可溶性E-cadherin水平,发现可溶性E-cadherin水平升高与预后不良密切相关。这些数据强烈提示血清可溶性e -钙粘蛋白可能是预测远处转移非常有用的参数。少
英文摘要
1. Multifactorial analysis of p53 alteration in mesopharyngeal carcinoma : Immunohistological staining for the detection of p53 protein was performed. Significant overexpression was observed in 15 of 26 tumors (62%). In clinical stages III and IV, a five-year overall survival of patients with p53 overexpression was 0%, showing apparent contrast to 41.7% for the negative patients. A p53 antibody in the sera of mesopharyngeal carcinoma patients was measured by ELISA.4O% of the patients were positive for p53 antibody. Serological analysis is advantageous because it does not require tumor samples. Furthermore, it can be used for the follow-up of patients.2. Implication of adhesion molecules, proteolytic enzymes and angiogenic factors in head and neck cancer metastasis : Study of E-cadherin expression in head and neck cancer tissues and its relation with survival rate revealed that decreased E-cadherin expression was correlated with poor prognosis. Thus, the function of E-cadherin may be cl … More osely related with metastatic activity of tumor cells. Angiogenesis is required for expansion of metastatic colonies as well as tumor growth. Cell lines derived from head and neck cancer cells showed significant production of vascular endothelial growth factor (VEGF), a most common angiogenic factor, indicating that tumor cells induce angiogenesis for their own growth. Combination of the immunohistochemical technique and computer-image analysis clearly showed that microvascular density was an important prognostic factor for distant metastasis in head and neck cancer. Suppression of E-cadherin function by anti-E-cadherin antibody upregulated the production of VEGF, which strongly support the close relationship between E-cadherin function and angiogenesis. Evaluation of soluble E-cadherin in sera of head and neck cancer patients by ELISA revealed that an increase of soluble E-cadherin closely related to poorer prognosis. The data strongly suggest that serum soluble E-cadherin may be very useful parameter predicting distant metastasis. Less
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
山中昇: "鼻・副鼻腔疾患と分子生物学in CLIENT21鼻"中山書店. 84-96 (2000)
Noboru Yamanaka:“CLIENT21 鼻子中的鼻/鼻窦疾病和分子生物学”Nakayama Shoten 84-96 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoda J, Tamura S, Takano I, Yamanaka N, et al: "Multifactorial analysis of p53 alteration in mesopharyngeal cancer"Jpn J StomatoPharyngol. 11. 321-327 (1999)
Yoda J、Tamura S、Takano I、Yamanaka N 等人:“间咽癌中 p53 改变的多因素分析”Jpn J StomatoPharyngol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
山中昇: "耳鼻咽喉科領域の分子生物学,分子遺伝子学-発癌と癌遺伝子"日本耳鼻咽喉科学会誌. 101. 66-69 (1998)
Noboru Yamanaka:“耳鼻喉科领域的分子生物学和分子遗传学 - 癌发生和致癌基因”日本耳鼻喉科学会杂志 101. 66-69 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
山中昇: "近年における腫瘍免疫研究の進歩とその臨床応用"日本耳鼻咽喉科免疫アレルギー. 17. 1-7 (1999)
Noboru Yamanaka:“肿瘤免疫研究及其临床应用的最新进展”日本耳鼻喉科免疫学和过敏学17. 1-7 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Pathogenesis research of pediatric intractable otitis media and viral-bacterial interaction
    • 批准号:
      21592165
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      YAMANAKA Noboru
    • 依托单位:
    A study of pathogenesis of intractable otitis media and activation of natural and specific immunities against pathogens
    • 批准号:
      19591987
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2007
    • 负责人:
      YAMANAKA Noboru
    • 依托单位:
    Immunological and molecular-biological studies on pathogenesis and treatments of intractable obits media
    • 批准号:
      17591797
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      YAMANAKA Noboru
    • 依托单位:
    MOLECULAR-BIOLOGICAL APPROACHES TO CARCINOGENESIS AND METASTASIS OF HEAD AND NECK CANCER AND THEIR APPLICATIONS TO IMMUNO-GENETIC THERAPY
    • 批准号:
      13470362
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.18万
    • 财政年份:
      2001
    • 负责人:
      YAMANAKA Noboru
    • 依托单位:
    国内基金
    海外基金
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究